These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 591144)

  • 21. Development of injectable microcapsules for use in the treatment of narcotic addiction.
    Thies C
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):19-20. PubMed ID: 1241971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis and modification of opiate reinforcement.
    Meyer RE; McNamee HB; Mirin SM; Altman JL
    Int J Addict; 1976; 11(3):467-84. PubMed ID: 184053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The structure-action relationship and kinetics of some naloxone and naltrexone derivatives.
    Vizi ES; Foldes FF; Rich J; Knoll J
    Pharmacology; 1976; 14(1):76-85. PubMed ID: 959310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with naltrexone.
    O'Brien CP; Greenstein RA; Mintz J; Woody GE
    Am J Drug Alcohol Abuse; 1975; 2(3-4):365-77. PubMed ID: 1227298
    [No Abstract]   [Full Text] [Related]  

  • 25. Narcotic antagonists: naltrexone progress report: introduction.
    Renault PF
    NIDA Res Monogr; 1976 Sep; (9):1-3. PubMed ID: 794713
    [No Abstract]   [Full Text] [Related]  

  • 26. Narcotic antagonist treatment of the criminal justice patient-institutional vs outpatient-including a 24 hour detox naltrexone induction regimen with oral medication.
    Brahen L; Wiechert V; Capone T
    NIDA Res Monogr; 1976 Sep; (9):93-8. PubMed ID: 794727
    [No Abstract]   [Full Text] [Related]  

  • 27. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclazocine in the treatment of opiate addiction: a review with recommendations.
    Goldstein MJ
    Int J Addict; 1980 Oct; 15(7):939-56. PubMed ID: 6256300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of naltrexone, a long-acting opiate antagonist.
    Crabtree BL
    Clin Pharm; 1984; 3(3):273-80. PubMed ID: 6329589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid opioid detoxification.
    Brewer C; Gastfriend DR
    JAMA; 1998 Jun; 279(23):1872. PubMed ID: 9634251
    [No Abstract]   [Full Text] [Related]  

  • 31. The diverse clinical uses of opioid receptor drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 May; 48(5):11-4. PubMed ID: 20415289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term effects of naltrexone in 155 heroin ex-addicts.
    Volavka J; Resnick RB; Kestenbaum RS; Freedman AM
    Biol Psychiatry; 1976 Dec; 11(6):679-85. PubMed ID: 999987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long acting delivery systems for narcotic antagonists II: release rates of naltrexone from poly(lactic acid) composites.
    Yolles S; Leafe TD; Woodland JH; Meyer FJ
    J Pharm Sci; 1975 Feb; 64(2):348-9. PubMed ID: 1127596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid antagonists.
    Barnett V; Twycross R; Mihalyo M; Wilcock A
    J Pain Symptom Manage; 2014 Feb; 47(2):341-52. PubMed ID: 24512968
    [No Abstract]   [Full Text] [Related]  

  • 35. Narcotic antagonists: naltrexone progress report: foreword.
    Jaffe J
    NIDA Res Monogr; 1976 Sep; (9):v-vii. PubMed ID: 1088898
    [No Abstract]   [Full Text] [Related]  

  • 36. Research and development of naltrexone: a new narcotic antagonist.
    Julius DA
    Am J Psychiatry; 1979 Jun; 136(6):782-6. PubMed ID: 220890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opiate receptor antagonists for delusions of parasitosis.
    Botschev C; Müller N
    Biol Psychiatry; 1991 Sep; 30(5):530-1. PubMed ID: 1657224
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical studies of cyclazocine in the treatment of narcotic addiction.
    Freedman AM; Fink M; Sharoff R; Zaks A
    Am J Psychiatry; 1968 May; 124(11):1499-504. PubMed ID: 4869436
    [No Abstract]   [Full Text] [Related]  

  • 39. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonist treatment of opioid withdrawal translational low dose approach.
    Mannelli P; Gottheil E; Van Bockstaele EJ
    J Addict Dis; 2006; 25(2):1-8. PubMed ID: 16785213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.